Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shelly Kafka"'
Autor:
Jeffrey R. Curtis, Yujie Su, Shawn Black, Stephen Xu, Wayne Langholff, Clifton O. Bingham, Shelly Kafka, Fenglong Xie
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 12, Pp 995-1003 (2022)
Objective Patient‐reported outcome (PRO) data have assumed increasing importance in the care of patients with rheumatoid arthritis (RA), yet physician‐derived disease activity measures, such as Clinical Disease Activity Index (CDAI), remain the m
Externí odkaz:
https://doaj.org/article/200a282c61cd4c1d859ce7c777e38f37
Autor:
Philip Mease, M. Elaine Husni, Soumya D. Chakravarty, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C. Hsia, Arthur Kavanaugh
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 11, Pp 640-647 (2020)
Objective To evaluate whether intravenous (IV) golimumab produces improvements in skin and nail symptoms that are concomitant with improvements in quality of life (QoL) and joint symptoms in patients with psoriatic arthritis. Methods Patients were ra
Externí odkaz:
https://doaj.org/article/16791a817ad3468185cd6445bb00e287
Autor:
Philip Mease, M. Elaine Husni, Shelly Kafka, Soumya D. Chakravarty, Diane D. Harrison, Kim Hung Lo, Stephen Xu, Elizabeth C. Hsia, Arthur Kavanaugh
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background In the GO-VIBRANT trial of intravenous golimumab in psoriatic arthritis (PsA), golimumab significantly inhibited radiographic progression. In post hoc analyses, we evaluated changes in total PsA-modified Sharp/van der Heijde score
Externí odkaz:
https://doaj.org/article/945104ccbdc445aca228892252650489
Autor:
Christopher T. Ritchlin, Mona Stahle, Yves Poulin, Jerry Bagel, Soumya D. Chakravarty, Shelly Kafka, Bhaskar Srivastava, Wayne Langholff, Alice B. Gottlieb
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-13 (2019)
Abstract Background Patients with psoriatic arthritis (PsA) have increased risk of adverse events, including serious infections (SI), compared with psoriasis patients. Methods Patients eligible for, or receiving conventional systemic and biologic age
Externí odkaz:
https://doaj.org/article/7b610315eb0d40c1a38aadfc14a63da9
Autor:
John Tesser, Shelly Kafka, Raphael J. DeHoratius, Stephen Xu, Elizabeth C. Hsia, Anthony Turkiewicz
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-9 (2019)
Abstract Objective To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged
Externí odkaz:
https://doaj.org/article/5fcf4bf9f6e94dd3964baebe663bd90d
Autor:
Arthur Kavanaugh, Lianne S Gensler, Philip S Helliwell, Kristen Sweet, Yin You, Soumya D Chakravarty, Shelly Kafka, Chetan S Karyekar, Kim Campbell
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Background The interleukin-12/23p40-subunit-inhibitor ustekinumab significantly improved spondylitis-related symptoms through Week 24 in psoriatic arthritis (PsA) patients with peripheral arthritis and physician-reported spondylitis (PA-PRS) in PSUMM
Externí odkaz:
https://doaj.org/article/3be774b727244c9f891bb653b2fa9ad5
Autor:
Arthur Kavanaugh, Kim Papp, Alice B. Gottlieb, Elke M. G. J. de Jong, Soumya D. Chakravarty, Shelly Kafka, Wayne Langholff, Kamyar Farahi, Bhaskar Srivastava, Jose U. Scher
Publikováno v:
BMC Rheumatology, Vol 2, Iss 1, Pp 1-10 (2018)
Abstract Background To evaluate demographics, family history, and previous medication use at enrollment in a subset of psoriasis patients with self-reported psoriatic arthritis (PsA) enrolled in Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Externí odkaz:
https://doaj.org/article/4f5c6b72b6e84626be65abf204c5e4a4
Autor:
Jeffrey R. Curtis, Yujie Su, Shawn Black, Stephen Xu, Wayne Langholff, Clifton O. Bingham, Shelly Kafka, Fenglong Xie
Publikováno v:
ACR Open Rheumatology. 4:995-1003
Patient-reported outcome (PRO) data have assumed increasing importance in the care of patients with rheumatoid arthritis (RA), yet physician-derived disease activity measures, such as Clinical Disease Activity Index (CDAI), remain the most accepted m
Autor:
John D, Reveille, Mark C, Hwang, Abhijeet, Danve, Shelly, Kafka, Steven, Peterson, Kim Hung, Lo, Lilianne, Kim, Elizabeth C, Hsia, Eric K H, Chan, Atul, Deodhar
Publikováno v:
Clinical rheumatology. 40(4)
The effect of intravenous (IV) golimumab on health-related quality of life (HRQoL) and productivity in patients with ankylosing spondylitis (AS) was evaluated.Patients were randomized to IV golimumab 2 mg/kg (n = 105) at weeks 0, 4, then every 8 week
Autor:
Proton Rahman, Alice B. Gottlieb, Lluís Puig, Christopher T. Ritchlin, Yin You, Michael Song, G. James Morgan, Shelly Kafka, Iain B. McInnes, Arthur Kavanaugh
Publikováno v:
The Journal of rheumatology. 46(11)
Objective.Evaluate enthesitis, physical function, and health-related quality of life (HRQOL) among patients with psoriatic arthritis (PsA) who are naive to anti–tumor necrosis factor agents.Methods.In PSUMMIT 1 and 2, patients with PsA were randomi